BRAIN TUMOR TREATMENT

To schedule an appointment 1-800-CEDARS-1 (1-800-233-2771) OR EMAIL US HERE

print button
Bios:

Surasak Phuphanich, MD

  • Director, Neuro-Oncology Program, Department of Neurosurgery and Division of Neurology

Surasak Phuphanich, MD, has devoted his professional life to improving treatment options for patients with brain tumors, particularly malignancies. He has more than 20 years’ experience in the field of translational clinical research – bringing research findings to clinical trials and putting them into practice in patients’ lives.

Scientists are now identifying the genes, proteins and mechanisms within cancer cells that allow tumors to grow. Although tumors of a particular type have many characteristics in common, there also are individual differences in composition. In research and in patient care, Dr. Phuphanich’s objective is to target vulnerable tumor cell components through individually designed, patient-specific treatments.

Before coming to Cedars-Sinai, Dr. Phuphanich was a professor of hematology-oncology, clinical program leader in neuro-oncology and co-principal investigator at the Winship Cancer Institute at Emory University. Previously, he was a founding physician and program leader at the Moffitt Cancer Center & Research Institute in Tampa, FL.

Throughout his career, Dr. Phuphanich has been an organizer and leader of educational conferences for neuro-oncologists, and his research has been widely published.

Present:
• Fellow, American Academy of Neurology (FAAN)
• American Association for Cancer Research (AACR)
• Society for Neuro-Oncology
• Member, several working committees of the New Approaches to Brain Tumor Therapy Consortium
• Member, Brain Tumor Committee, Easter Cooperative Oncology Group
• Member, Brain Committee, Radiation Therapy Oncology Group (RTOG)
• Member, Intervention Neurology, American Academy of Neurology (AAN)
• Member, Neuro-Oncology, American Academy of Neurology (AAN)
• American Society of Clinical Oncology (ASCO)
• Member, Editorial Board, Current Cancer Drug Targets
• Member, Editorial Board, Current Cancer Therapy Reviews
• Member, Editorial Board, American Journal of Clinical Oncology

Past:
• American Epilepsy Society (AES)
• American Society of Neuro-imaging (ASN)
• Member, Executive committee, New Approaches to Brain Tumor Therapy Consortium

• Recipient of numerous awards for quality in clinical trials
• Named one of America’s Top Doctors for Cancer since 2006
• Listed as one of America’s Top Oncologists for 2009
• Received Georgia Cancer Coalition Distinguished Clinical Investigator Professional Award, 2004-2007

• Bachelor’s Degree: Mahidol University, Bangkok, Thailand, 1973
• Medical Degree: Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 1975
• Internship: Internal medicine and psychiatry, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 1975-1977
• Residency: Internal medicine, Saint Francis Hospital, Evanston, IL, 1977-1978
• Residency: Neurology, University of Illinois Hospital, Chicago, IL, 1978-1981
• Fellowship: Clinical research, neuro-oncology, Brain Tumor Research Center, Department of Neurosurgery, University of California, San Francisco

Back to top
© 2013 All rights reserved. Cedars-Sinai
7-X